These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18790777)

  • 1. N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing.
    Wang H; Maurer BJ; Liu YY; Wang E; Allegood JC; Kelly S; Symolon H; Liu Y; Merrill AH; Gouazé-Andersson V; Yu JY; Giuliano AE; Cabot MC
    Mol Cancer Ther; 2008 Sep; 7(9):2967-76. PubMed ID: 18790777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
    Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase.
    Wang H; Maurer BJ; Reynolds CP; Cabot MC
    Cancer Res; 2001 Jul; 61(13):5102-5. PubMed ID: 11431347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
    O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ
    Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
    Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
    Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
    Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
    BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines.
    Holliday MW; Cox SB; Kang MH; Maurer BJ
    PLoS One; 2013; 8(9):e74768. PubMed ID: 24040340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.
    Apraiz A; Idkowiak-Baldys J; Nieto-Rementería N; Boyano MD; Hannun YA; Asumendi A
    Biochem Cell Biol; 2012 Apr; 90(2):209-23. PubMed ID: 22428532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cells.
    Mao Z; Sun W; Xu R; Novgorodov S; Szulc ZM; Bielawski J; Obeid LM; Mao C
    J Biol Chem; 2010 Sep; 285(38):29078-90. PubMed ID: 20628055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids.
    Valsecchi M; Aureli M; Mauri L; Illuzzi G; Chigorno V; Prinetti A; Sonnino S
    J Lipid Res; 2010 Jul; 51(7):1832-40. PubMed ID: 20194109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
    Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
    J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hayashi Y; Tsuchiya K; Yamamoto M; Nemoto-Sasaki Y; Tanigawa K; Hama K; Ueda Y; Tanikawa T; Gohda J; Maeda K; Inoue JI; Yamashita A
    J Virol; 2021 Aug; 95(17):e0080721. PubMed ID: 34106748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells.
    Rother J; van Echten G; Schwarzmann G; Sandhoff K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):14-20. PubMed ID: 1449467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells.
    Messner MC; Cabot MC
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):477-87. PubMed ID: 21072519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.
    Illuzzi G; Bernacchioni C; Aureli M; Prioni S; Frera G; Donati C; Valsecchi M; Chigorno V; Bruni P; Sonnino S; Prinetti A
    J Biol Chem; 2010 Jun; 285(24):18594-602. PubMed ID: 20404323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.
    Ahn EH; Schroeder JJ
    Exp Biol Med (Maywood); 2002 May; 227(5):345-53. PubMed ID: 11976405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
    Wang H; Charles AG; Frankel AJ; Cabot MC
    Urology; 2003 May; 61(5):1047-52. PubMed ID: 12736045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.